BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
-20.17%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.95B
AUM Growth
-$568M
Cap. Flow
+$92.5M
Cap. Flow %
4.76%
Top 10 Hldgs %
47.94%
Holding
79
New
8
Increased
5
Reduced
2
Closed
4

Top Buys

1
APLS icon
Apellis Pharmaceuticals
APLS
+$66.2M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$64.7M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$40.6M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$28.3M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$26.1M

Top Sells

1
XBI icon
SPDR S&P Biotech ETF
XBI
+$135M
2
ITOS
iTeos Therapeutics
ITOS
+$37.1M
3
RACB
Research Alliance Corp. II Class A Common Stock
RACB
+$4.89M
4
JYAC
Jiya Acquisition Corp. Class A Common Stock
JYAC
+$4.89M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$3.96M

Sector Composition

1 Healthcare 96.15%
2 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FOLD icon
26
Amicus Therapeutics
FOLD
$2.46B
$22M 1.13%
2,325,000
– –
BLU
27
DELISTED
BELLUS Health Inc.
BLU
$22M 1.13%
3,200,000
– –
GOSS icon
28
Gossamer Bio
GOSS
$787M
$21.4M 1.1%
2,462,358
– –
KNTE
29
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$20.8M 1.07%
1,847,559
– –
RNA icon
30
Avidity Biosciences
RNA
$5.76B
$20.7M 1.06%
1,121,327
– –
PNT
31
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$19.9M 1.02%
2,500,000
– –
FATE icon
32
Fate Therapeutics
FATE
$111M
$19.4M 1%
500,000
– –
GHRS icon
33
GH Research
GHRS
$741M
$18.5M 0.95%
1,013,399
– –
XENE icon
34
Xenon Pharmaceuticals
XENE
$2.79B
$18.3M 0.94%
600,000
– –
NRIX icon
35
Nurix Therapeutics
NRIX
$691M
$17.2M 0.88%
1,224,892
– –
NUVL icon
36
Nuvalent
NUVL
$5.8B
$16.8M 0.86%
1,210,192
– –
RARE icon
37
Ultragenyx Pharmaceutical
RARE
$2.92B
$14.5M 0.75%
200,000
– –
MIST icon
38
Milestone Pharmaceuticals
MIST
$167M
$14.4M 0.74%
2,238,861
– –
DAWN icon
39
Day One Biopharmaceuticals
DAWN
$729M
$11.8M 0.61%
1,189,943
– –
AKRO icon
40
Akero Therapeutics
AKRO
$3.48B
$11.8M 0.61%
831,495
– –
CNTA
41
Centessa Pharmaceuticals
CNTA
$2.92B
$11.3M 0.58%
1,251,137
– –
CGEM icon
42
Cullinan Oncology
CGEM
$386M
$11.2M 0.58%
1,074,082
– –
PRTA icon
43
Prothena Corp
PRTA
$442M
$11M 0.56%
300,000
– –
TPTX
44
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$10.7M 0.55%
+400,000
New +$10.7M
THRX
45
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$10.3M 0.53%
892,057
– –
TSVT
46
DELISTED
2seventy bio
TSVT
$7.85M 0.4%
+459,836
New +$7.85M
NGM
47
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$7.63M 0.39%
500,000
– –
BCEL
48
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$6.98M 0.36%
2,202,333
– –
SLDB icon
49
Solid Biosciences
SLDB
$420M
$6.4M 0.33%
355,735
+143,888
+68% +$2.59M
RAIN
50
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$5.96M 0.31%
1,175,000
– –
1
2
3 4